Clinical Trial Update: Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males [Phase 1]

View source ↗

Summary

This Phase 1 safety study of GSI-136 in young and elderly Japanese males, including participants with Alzheimer's disease and healthy volunteers, has completed.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GSI-136 (GSI-136)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Alzheimer Disease, Healthy | Phase 1 | Status: COMPLETED